Table 1.
EM | Premenopausal luteal phase women N = 264 | Premenopausal non-luteal phase women N=98 | Postmenopausal women N =168 |
---|---|---|---|
Spearman correlations | |||
RIA and LC/MS2 | |||
Estrone | 0.94 | 0.96 | 0.79 |
Estradiol | 0.91 | 0.95 | 0.63 |
Estriol | 0.94 | 0.94 | 0.73 |
ELISA and LC/MS2 | |||
2-Hydroxyestrone | 0.81 | 0.89 | 0.37 |
16α-Hydroxyestrone | 0.86 | 0.89 | 0.62 |
Geometric mean concentrations pmol/mg creatinine | ||||||
---|---|---|---|---|---|---|
RIA/ELISA | LC/MS2 | RIA/ELISA | LC/MS2 | RIA/ELISA | LC/MS2 | |
RIA and LC/MS2 | ||||||
Estrone | 41.9 | 23.4 | 27.9 | 14.6 | 6.9 | 2.6 |
Estradiol | 17.6 | 10.9 | 12.0 | 7.7 | 2.1 | 1.5 |
Estriol | 77.2 | 55.5 | 50.1 | 31.2 | 12.9 | 5.7 |
ELISA and LC/MS2 | ||||||
2-Hydroxyestrone | 47.8 | 24.6 | 31.0 | 13.8 | 18.6 | 2.9 |
16α-Hydroxyestrone | 32.2 | 11.0 | 23.8 | 6.5 | 14.1 | 1.2 |
Subjects are Asian–American women, aged 20–55 years, selected as controls for a population-based case-control study of breast cancer [29]. 12 h overnight urines were collected.